Cell line · CVCL_0005
NB4
Cancer cell line, Homo sapiens. Acute promyelocytic leukemia with PML-RARA. 62 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. NB4. Cell lines, record CVCL_0005. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0005
On this page
Cell line
As Cellosaurus gives it.
- Name
- NB4
- Accession
- CVCL_0005
- RRID
- RRID:CVCL_0005
- Synonyms
- NB-4, NB.4
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 23Y
- Category
- Cancer cell line
- Diseases
- Acute promyelocytic leukemia with PML-RARA (NCIt C3182); Acute promyelocytic leukemia (ORDO Orphanet_520)
- Derived from
- Bone marrow (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers62
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Extracellular vesicle-delivered siRNA targeting RCN1 suppresses acute myeloid leukemia through TFAM-dependent mtDNA-cGAS-STING signaling. | Extracell Vesicles Circ Nucl Acids | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Greatwall kinase regulates acute myeloid leukaemia cell division through a non-canonical mechanism. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Novel noscapine derivative induces AML differentiation by dual-engaging DHODH and mitochondrial lipids to trigger a metabolic-epigenetic-transcriptional cascade. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A structure-based modeling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intracellular iron homeostasis-regulated epigenetic reprogramming contributes to -7/del(7q) leukemia. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative multi-omics, machine learning, and experimental validation reveal that TPM1 suppresses M2 macrophage polarization and enhances chemosensitivity in acute myeloid leukemia. | Cell Biol Toxicol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Sialic acid cis-ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity. | Oncoimmunology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBM15B recognizes H3K79me2 to guide selective m6A-modification of mRNA and enhance oncoprotein translation in MLL-r leukemia. | EMBO J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ΔNp73 isoform defines a TP53-mutant-like poor-risk subgroup of acute myeloid leukemia. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein. | BMC Cancer | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 62
See all 62 papersRelatives15
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE NB4-Cas9 | CVCL_F5R0 | Cell lines | |
| Derived from it | HyCyte NB4 stable cell line for hBCL6B overexpression | CVCL_F4SQ | Cell lines | |
| Derived from it | NB4-A1 | CVCL_VV77 | Cell lines | |
| Derived from it | NB4-AsR | CVCL_U080 | Cell lines | |
| Derived from it | NB4-B1 | CVCL_VV78 | Cell lines | |
| Derived from it | NB4-D5 | CVCL_VV79 | Cell lines | |
| Derived from it | NB4-DR1 | CVCL_U085 | Cell lines | |
| Derived from it | NB4-LR1 | CVCL_8811 | Cell lines | |
| Derived from it | NB4-S1 | CVCL_U086 | Cell lines | |
| Derived from it | NB4.007/6 | CVCL_U083 | Cell lines |
1 to 10 of 15
See all 15 relativesCell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 300299 | CLS | |
| DSMZ | ACC-207 | DSMZ | |
| EDITGENE | EDC00350 | EDITGENE | |
| NCBI_Iran | C515 | Cellosaurus | |
| Ubigene | YC-C122 | Ubigene |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0005
GET https://conductscience.org/api/cell-lines/v1/CVCL_0005/papers?page=2